SUSTAINABILITY OF RESPONSE TO UPADACITINIB AMONG PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS REFRACTORY TO BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS-MedSci.cn

SUSTAINABILITY OF RESPONSE TO UPADACITINIB AMONG PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS REFRACTORY TO BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS

van Vollenhoven, R; Hall, S; Wells, AF; Meerwein, S; Song, YN; Suboticki, JL; Fleischmann, R

INTERNAL MEDICINE JOURNAL, 2022; 52 (): 29

科室
- - 订阅+
  - 更多科室
工具
服务